ILA 690
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Epitomee Medical Ltd, an Israeli-based biomedical enterprise established in 2005, specializes in creating and distributing oral therapeutic devices globally. Its flagship product, a capsule, is designed to assist with weight management, decrease waist circumference, and reduce factors contributing to cardiovascular risk. The company maintains a strategic alliance with Nestlé Health Science S.A. for the advancement and market introduction of this innovative weight loss solution.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers.
Data is available to registered users only